Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation.

Hanje AJ, Yao FY.

Curr Opin Organ Transplant. 2008 Jun;13(3):234-40. doi: 10.1097/MOT.0b013e3282fc2633. Review.

PMID:
18685309
2.
3.

A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.

Yao FY, Hirose R, LaBerge JM, Davern TJ 3rd, Bass NM, Kerlan RK Jr, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP.

Liver Transpl. 2005 Dec;11(12):1505-14.

4.

Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria.

Yao FY.

Am J Transplant. 2008 Oct;8(10):1982-9. doi: 10.1111/j.1600-6143.2008.02351.x. Review.

5.
6.

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.

Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, Hoppe-Lotichius M, Schuchmann M, Victor A, Pitton M.

Liver Transpl. 2006 Aug;12(8):1260-7.

7.

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.

Herrero JI, Sangro B, Pardo F, Quiroga J, Iñarrairaegui M, Rotellar F, Montiel C, Alegre F, Prieto J.

Liver Transpl. 2008 Mar;14(3):272-8. doi: 10.1002/lt.21368.

8.

Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.

Santoyo J, Sanchez B, de la Mata M, Fernández-Aguilar JL, Lopez-Ciller P, Pascasio JM, Suarez MA, Gomez MA, Nogueras F, Muffak K, Cuende N, Alonso M.

Transplant Proc. 2009 Apr;41(3):1009-11. doi: 10.1016/j.transproceed.2009.02.028.

PMID:
19376412
9.

Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.

Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, Margreiter R, Vogel W.

Liver Transpl. 2007 Feb;13(2):272-9.

10.

Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.

Sotiropoulos GC, Molmenti EP, Omar OS, Bockhorn M, Brokalaki EI, Lang H, Frilling A, Broelsch CE, Malagó M.

Eur J Med Res. 2006 Nov 30;11(11):467-70.

PMID:
17182358
11.

Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors.

Sotiropoulos GC, Lang H, Nadalin S, Neuhäuser M, Molmenti EP, Baba HA, Paul A, Saner FH, Weber F, Hilgard P, Frilling A, Broelsch CE, Malagó M.

J Am Coll Surg. 2007 Nov;205(5):661-75.

PMID:
17964442
12.

Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation.

Shi XJ, Jin X, Wang MQ, Wei LX, Ye HY, Liang YR, Luo Y, Dong JH.

Hepatobiliary Pancreat Dis Int. 2011 Apr;10(2):143-50.

13.

Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there.

Llovet JM, Schwartz M, Fuster J, Bruix J.

Semin Liver Dis. 2006 Aug;26(3):248-53.

PMID:
16850374
14.

Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?

Yao FY, Fidelman N.

Hepatology. 2016 Mar;63(3):1014-25. doi: 10.1002/hep.28139. Review.

PMID:
26560491
15.

Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.

D'Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, Thung S, Guido M, del Rio Martin J, Schiano T, Cillo U.

Liver Transpl. 2009 Oct;15(10):1278-87. doi: 10.1002/lt.21842.

16.

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.

Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, Magee JC, Lok AS, Fontana RJ, Marrero JA.

Liver Transpl. 2009 Aug;15(8):859-68. doi: 10.1002/lt.21778.

17.

Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.

Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD, Brown DB.

Ann Surg. 2008 Oct;248(4):617-25. doi: 10.1097/SLA.0b013e31818a07d4.

PMID:
18936575
18.

[Value of liver transplantation in hepatocellular carcinoma treatment].

Zheng SS, Wu J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):366-70. Chinese.

19.

Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.

Sharr WW, Chan SC, Lo CM.

Transplantation. 2014 Apr 27;97 Suppl 8:S10-7. doi: 10.1097/01.tp.0000446267.19148.21. Review.

PMID:
24849822
20.

Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the selection criteria?

Sauer P, Kraus TW, Schemmer P, Mehrabi A, Stremmel W, Buechler MW, Encke J.

Transplantation. 2005 Sep 27;80(1 Suppl):S105-8. Review.

PMID:
16286885
Items per page

Supplemental Content

Support Center